Skip to search formSkip to main contentSkip to account menu

MP Regimen (Mitoxantrone-Prednisone)

Known as: MP Regimen, Mitoxantrone-Prednisone Regimen 
A regimen consisting of mitoxantrone and prednisone used to treat metastatic hormone-refractory prostate cancer.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Dear Editor, A 32-year-old woman was admitted because of progressive numbness in the lower limbs for 15 months, accompanied with… 
2000
2000
Objective To compare the therapeutic effect between VAD and MP regimen in initial untreated patients with multiple myeloma(MM… 
1987
1987
Six patients with multiple myeloma were treated with HLBI-MP regimen; HLBI 300 X 10(4)U/day daily, Melphalan 4 mg/day p.o. from…